M. N. A. Mukri, “Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial”, EXCLI J., vol. 17, pp. 563–575, Jun. 2018.